IFNAR1 and infection: Notably, the clinical progression, timing of symptom onset, and mortality observed in our study closely resembled those reported by Meier et al. (2009) [20], suggesting that infection with WT YFV via the subcutaneous route produces comparable disease in IFNAR1−/− mice across different genetic backgrounds.